Price $3.99 |
Market Cap
67.2M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
37.3
|
P/B
0.75
|
P/S
1.42
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-22.7K
|
FCF
-1.2
|
|
Op. Margin
0.40%
|
Net Margin
4.10%
|
ROE
2.20%
|
ROI
-23.40%
|
|
ROA
1.70%
|
EPS Growth
109.80%
|
Current Ratio
7.6
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| R1 RCM Inc (RCM) | $11.80 | - | - | 1.32B | Strong Buy |
| Allergan plc (AGN) | $115.73 | - | 2.40% | 40.13B | Strong Buy |
| Allied Healthcare Products Inc (AHPI) | $1.88 | - | - | 7.5M | Strong Buy |
| Fulgent Genetics Inc (FLGT) | $5.78 | - | - | 106.5M | Strong Buy |
| Cesca Therapeutics Inc (KOOL) | $2.79 | - | - | 6.1M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
